These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31433337)

  • 1. Delayed Onset Postinjection Delirium/Sedation Syndrome Associated With Olanzapine Pamoate: A Case Report.
    Garg S; Gupta D; Rakesh K; Tikka SK
    J Clin Psychopharmacol; 2019; 39(5):523-524. PubMed ID: 31433337
    [No Abstract]   [Full Text] [Related]  

  • 2. Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot Injection.
    Venkatesan V; Khanra S; Mandal K; Deepak MB
    Clin Neuropharmacol; 2019; 42(2):64-65. PubMed ID: 30747749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
    Novakovic V; Adel T; Peselow E; Lindenmayer JP
    Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Olanzapine post-injection delirium/sedation syndrome mimicking brainstem-thrombosis.
    Pollentier A; Vergaelen M; De Bleecker JL
    Acta Neurol Belg; 2021 Oct; 121(5):1383-1384. PubMed ID: 34009531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
    Buts K; Van Hecke J
    Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine postinjection delirium/sedation syndrome: an unrecognized diagnosis in the emergency department.
    Vodovar D; Malissin I; Deye N; Baud FJ; Mégarbane B
    J Emerg Med; 2014 Jul; 47(1):e23-4. PubMed ID: 24199723
    [No Abstract]   [Full Text] [Related]  

  • 7. Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.
    Kokalj A; Rijavec N; Tavčar R
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Mohammad M; Alaoui-Ismaili Z; Baandrup L; Barzanji AF
    Ugeskr Laeger; 2023 May; 185(19):. PubMed ID: 37170738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation.
    Chartier F; Rouillon F; Berggren L; Jamonneau I; Falissard B; Llorca PM
    Encephale; 2017 Aug; 43(4):303-310. PubMed ID: 28709669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic.
    Siskind D; Northwood K; Berk M; Castle D; Galletly C; Harris A
    Aust N Z J Psychiatry; 2020 Jul; 54(7):759-761. PubMed ID: 32406764
    [No Abstract]   [Full Text] [Related]  

  • 11. Worsening of Myasthenia Gravis After Administration of Antipsychotics for Treatment of Schizophrenia: A Case Report and Review of Literature.
    She S; Yi W; Zhang B; Zheng Y
    J Clin Psychopharmacol; 2017 Oct; 37(5):620-622. PubMed ID: 28640071
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine-Induced Fever.
    Ferreira TF; Godinho FDG; Dehanov SD; Trancas B; Maia T
    Prim Care Companion CNS Disord; 2019 Feb; 21(1):. PubMed ID: 30817864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-injection syndrome and olanzapine pamoate: A severe case report].
    Descusse A; Chebili S; Artiges E
    Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting injectable olanzapine: post-injection syndrome.
    Prescrire Int; 2017 Feb; 26(179):46. PubMed ID: 30726633
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine-Olanzapine Drug-Drug Interaction.
    Robles-Martínez M; Monge MF; Iglesias-González M
    Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701931
    [No Abstract]   [Full Text] [Related]  

  • 16. Case series profile of olanzapine post-injection delirium/sedation syndrome.
    Seebaluck J; Downes MA; Brown J; Harris K; Isoardi KZ; Chan BS
    Br J Clin Pharmacol; 2023 Feb; 89(2):903-907. PubMed ID: 36349832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.
    Luedecke D; Schöttle D; Karow A; Lambert M; Naber D
    CNS Drugs; 2015 Jan; 29(1):41-6. PubMed ID: 25424243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Panieński P; Żaba C; Zielińska-Psuja B
    Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):213-4. PubMed ID: 25703610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness study of olanzapine pamoate: Mirror-image analysis after one year].
    Potaufeu J; Langrée B; Drapier D; Burgot G; Marie N
    Encephale; 2019 Jun; 45(3):232-238. PubMed ID: 30579574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine.
    Mustafa FA; Nayar A
    Psychopharmacol Bull; 2019 Jun; 49(2):63-64. PubMed ID: 31308585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.